Literature DB >> 11774240

Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells.

Anne Hansen Ree1, Olav Engebraaten, Eivind Hovig, Øystein Fodstad.   

Abstract

The red bone marrow (BM) is an important indicator organ of hematogenous micrometastatic spread of carcinomas. Characterization of biological properties specific for BM micrometastatic cells, however, is technically challenging due to the limited number of target cells usually available for the purpose. This report provides referrals to qualitative gene expression profiling of BM micrometastatic cells enriched by immunomagnetic selection. First, an experimental strategy was used to study regulatory mechanisms involved when BM micrometastatic cells colonize distant organs. The MA-11 cells, originating from BM micrometastases in a breast cancer patient clinically devoid of overt metastatic disease, were injected into immunodeficient rats. Metastatic MA-11 cells were subsequently immunoselected from the resulting in vivo lesions. The selected cell populations were compared to the injected cells by differential display analysis, and several genes possibly involved in tumor cell invasion and proliferation were confirmed as differentially expressed among the various MA-11 cell populations. A direct approach to qualitative gene expression profiling of BM micrometastatic cells was also explored. Carcinoma cells were immunoselected from BM and axillary lymph nodes obtained from breast cancer patients, and the isolated cell populations were compared by differential display analysis. Two candidate genes, identified as factors involved in cellular growth control, appeared as differentially expressed by the target cells from BM. Our study provides detailed information on how to combine an immunomagnetic selection procedure and differential display analysis to reveal gene expression profiles that may characterize BM micrometastatic cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774240     DOI: 10.1002/ijc.1564

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.

Authors:  Rossella Solmi; Giampaolo Ugolini; Giancarlo Rosati; Simone Zanotti; Mattia Lauriola; Isacco Montroni; Marco del Governatore; Antonello Caira; Mario Taffurelli; Donatella Santini; Domenico Coppola; Lia Guidotti; Paolo Carinci; Pierluigi Strippoli
Journal:  BMC Cancer       Date:  2006-10-20       Impact factor: 4.430

2.  Influence of immunomagnetic enrichment on gene expression of tumor cells.

Authors:  Ute Woelfle; Elisabeth Breit; Klaus Pantel
Journal:  J Transl Med       Date:  2005-03-16       Impact factor: 5.531

3.  Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.

Authors:  Jonathan J Cools-Lartigue; Cristin S McCauley; Jean-Claude A Marshall; Sebastian Di Cesare; Francois Gregoire; Emilia Antecka; Patrick Logan; Miguel N Burnier
Journal:  Mol Vis       Date:  2008-01-10       Impact factor: 2.367

4.  Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.

Authors:  Valérie Choesmel; Jean-Yves Pierga; Claude Nos; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Jean-Paul Thiery; Nathalie Blin
Journal:  Breast Cancer Res       Date:  2004-07-29       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.